Kyle Munz

New biomarker technology shows promising results for predicting the prognosis of patients with prostate cancer after radical prostatectomy.

Researchers using the Big Five Inventory-2 Short Form questionnaire in a large-scale survey have associated certain personality traits with the openness to accept or refuse the COVID-19 vaccine.

Polymyalgia rheumatica (PMR) is an inflammatory disease often misdiagnosed as certain cancers, among other diseases. Researchers have recently made progress to better diagnose PMR using a standard uptake value index based on fluorodeoxyglucose with positron-emission tomography/computed tomography.

The body of research on nirmatrelvir-ritonavir demonstrates a plethora of benefits in the treatment of COVID-19, and authors of a recent study identified more advantages to administering the treatment to patients with COVID-19.

A recent study suggests that a lack of equitable access to care contributes to known disparities in outcomes between Black and White patients with advanced prostate cancer.

Researchers linking uric acid (UA) levels to the aggressiveness and progression of prostate cancer believe these findings can be used to study UA influence on prostate cancer–related mortality risk.

Researchers seeking answers regarding the most beneficial duration of immune checkpoint inhibitor–based therapy for non–small cell lung cancer (NSCLC) found no significant impact of indefinite-duration treatment on patient survival.

After the COVID-19 vaccine was released, disparities in COVID-19 incidence shrunk. However, although efforts were made to increase access to the COVID-19 vaccine in low-income areas, discrepancies in overall vaccination coverage persisted between higher- and lower-income communities.

Following prostatectomy in patients with recurrent prostate cancer, researchers analyzed post–salvage radiotherapy prostate-specific antigen (PSA) values and the percentages of PSA decline to anticipate patient survival rates.

Forms of localized treatment have potential to positively impact the survival rate and prognosis of men diagnosed with certain forms of metastatic prostate cancer.

Patient-centered care (PCC) is a major part of a patient’s daily life that addresses their psychological needs, among other needs and preferences. Quality PCC has been recognized as important in clinical practice; however, implementation rates remain comparatively low.

Most prostate cancer survivors surveyed reported feeling that telehealth cannot fully replace in-person visits, with perceptions varying significantly based on education level.